For decades, this company was the trusted companion in countless weight loss journeys.
Its structured approach, points-based food system, and celebrity endorsements made it a global leader in healthy living.
But times have changed — and this titan has struggled to keep up.
Even a powerhouse like Oprah Winfrey, once a board member and proud spokesperson, has stepped away.
Her admission that she turned to weight loss drugs as a “maintenance tool” signaled something much deeper: the world was moving on from traditional dieting methods.
The rise of the needle
In recent years, injectable weight loss drugs like Wegovy, Ozempic, and Mounjaro have taken the health and wellness world by storm.
These medications, originally developed for diabetes, are now being used widely off-label or with new approval to help users shed pounds more effectively than ever before.
By slowing the rate at which the stomach empties, they leave users feeling full longer — with dramatic results.
In the UK alone, half a million people have tried these injections.
In the US, more than 10 % of adults used them last year. According to Morgan Stanley, the global market for these drugs could soar to $105 billion by 2030.
As people ditch diet plans and calorie-counting apps for quick, clinical solutions, entire sectors are feeling the impact.
Even food retailers are reporting shrinking shopping baskets. The shift is seismic — and for some, catastrophic.
A legacy on the brink
The company WeightWatchers, once valued as a heavyweight in the wellness industry, has seen its revenue tumble by over $100 million in just a year.
Its share price has collapsed by more than 90 %. Credit rating agencies have lost confidence.
Now, reports suggest it is preparing for Chapter 11 bankruptcy proceedings to restructure its debt and hand control to creditors.
This article is based on information from The Telegraph.
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.